Bio-Rad Labs Inc. A buy Citigroup Inc.
Start price
31.10.24
/
50%
€329.60
Target price
31.10.25
€413.33
Performance (%)
-16.99%
End price
01.11.25
€273.60
Summary
This prediction ended on 01.11.25 with a price of €273.60. The prediction for Bio-Rad Labs Inc. A disappointed with a performance of -16.99%. Citigroup_Inc_ has a follow-up prediction for Bio-Rad Labs Inc. A where he still thinks Bio-Rad Labs Inc. A is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bio-Rad Labs Inc. A | 2.732% | 2.732% | 30.502% |
| iShares Core DAX® | 2,59 % | 2,69 % | 6,41 % |
| iShares Nasdaq 100 | -0,91 % | -7,37 % | 20,65 % |
| iShares Nikkei 225® | 0,15 % | -10,20 % | 46,17 % |
| iShares S&P 500 | -0,37 % | -0,83 % | 18,02 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Citigroup Inc. from $400.00 to $450.00. They now have a "buy" rating on the stock.
Ratings data for BIO provided by MarketBeat
In the thread Trading Bio-Rad Labs Inc. A
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€262.00
30.10.25
30.10.25
€322.88
30.10.26
30.10.26
8.02%
29.07.26
29.07.26
Stopped prediction by Citigroup_Inc_ for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€299.30
01.10.24
01.10.24
€361.20
01.10.25
01.10.25
-16.17%
02.10.25
02.10.25